Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion
Background and Objectives: Chronic total occlusion (CTO) is a complex lesion of coronary artery disease (CAD) with a detection rate of approximately 25% on coronary angiography. CTO patients generally experience poor quality of life and prognosis. This study aims to evaluate the association between...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-08-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/11/9/261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850260761137381376 |
|---|---|
| author | Wenjie Chen Yiming Liu Yuchen Shi Jinghua Liu |
| author_facet | Wenjie Chen Yiming Liu Yuchen Shi Jinghua Liu |
| author_sort | Wenjie Chen |
| collection | DOAJ |
| description | Background and Objectives: Chronic total occlusion (CTO) is a complex lesion of coronary artery disease (CAD) with a detection rate of approximately 25% on coronary angiography. CTO patients generally experience poor quality of life and prognosis. This study aims to evaluate the association between the estimated glucose disposal rate (eGDR), a surrogate marker for insulin resistance (IR), and the prognosis of CTO PCI patients, as well as to investigate the potential role of the systemic immune-inflammation index (SII) in this process. Methods: We retrospectively included 1482 non-diabetic patients who underwent successful CTO PCI at Anzhen Hospital between January 2018 and December 2021. The primary endpoint was major adverse cardiovascular events (MACEs). Clinical characteristics, biochemical markers, and interventional records were collected, and the eGDR and SII were calculated. Cox regression, restricted cubic splines (RCSs), receiver operating characteristic (ROC) analysis, and Kaplan–Meier curves were used to assess associations. Results: MACEs occurred in 158 patients (10.67%). Patients with MACEs had lower eGDR and higher SII levels. A high eGDR significantly reduced MACE risk (Q4 vs. Q1: HR 0.06, 95% CI 0.03–0.12), while a high SII increased it (Q4 vs. Q1: HR 3.32, 95% CI 1.78–6.33). The combination of low eGDRs and high SIIs predicted the highest MACE risk (HR 4.36, 95% CI 2.71–6.01). The SII partially mediated the relationship between eGDR and MACEs. Conclusions: A low eGDR and high SII are significant predictors of poor prognosis in non-diabetic CTO PCI patients. Combining the eGDR and the SII provides a comprehensive assessment for better predicting cardiovascular outcomes. |
| format | Article |
| id | doaj-art-18790928456447ed916cf498fbff87d8 |
| institution | OA Journals |
| issn | 2308-3425 |
| language | English |
| publishDate | 2024-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj-art-18790928456447ed916cf498fbff87d82025-08-20T01:55:34ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252024-08-0111926110.3390/jcdd11090261Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total OcclusionWenjie Chen0Yiming Liu1Yuchen Shi2Jinghua Liu3Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, 2 Anzhen Road, Chaoyang District, Beijing 100029, ChinaCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, 2 Anzhen Road, Chaoyang District, Beijing 100029, ChinaCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, 2 Anzhen Road, Chaoyang District, Beijing 100029, ChinaCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, 2 Anzhen Road, Chaoyang District, Beijing 100029, ChinaBackground and Objectives: Chronic total occlusion (CTO) is a complex lesion of coronary artery disease (CAD) with a detection rate of approximately 25% on coronary angiography. CTO patients generally experience poor quality of life and prognosis. This study aims to evaluate the association between the estimated glucose disposal rate (eGDR), a surrogate marker for insulin resistance (IR), and the prognosis of CTO PCI patients, as well as to investigate the potential role of the systemic immune-inflammation index (SII) in this process. Methods: We retrospectively included 1482 non-diabetic patients who underwent successful CTO PCI at Anzhen Hospital between January 2018 and December 2021. The primary endpoint was major adverse cardiovascular events (MACEs). Clinical characteristics, biochemical markers, and interventional records were collected, and the eGDR and SII were calculated. Cox regression, restricted cubic splines (RCSs), receiver operating characteristic (ROC) analysis, and Kaplan–Meier curves were used to assess associations. Results: MACEs occurred in 158 patients (10.67%). Patients with MACEs had lower eGDR and higher SII levels. A high eGDR significantly reduced MACE risk (Q4 vs. Q1: HR 0.06, 95% CI 0.03–0.12), while a high SII increased it (Q4 vs. Q1: HR 3.32, 95% CI 1.78–6.33). The combination of low eGDRs and high SIIs predicted the highest MACE risk (HR 4.36, 95% CI 2.71–6.01). The SII partially mediated the relationship between eGDR and MACEs. Conclusions: A low eGDR and high SII are significant predictors of poor prognosis in non-diabetic CTO PCI patients. Combining the eGDR and the SII provides a comprehensive assessment for better predicting cardiovascular outcomes.https://www.mdpi.com/2308-3425/11/9/261chronic total occlusion (CTO)percutaneous coronary intervention (PCI)estimated glucose disposal rate (eGDR)systemic immune-inflammation index (SII)major adverse cardiovascular events (MACEs) |
| spellingShingle | Wenjie Chen Yiming Liu Yuchen Shi Jinghua Liu Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion Journal of Cardiovascular Development and Disease chronic total occlusion (CTO) percutaneous coronary intervention (PCI) estimated glucose disposal rate (eGDR) systemic immune-inflammation index (SII) major adverse cardiovascular events (MACEs) |
| title | Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion |
| title_full | Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion |
| title_fullStr | Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion |
| title_full_unstemmed | Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion |
| title_short | Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion |
| title_sort | prognostic value of estimated glucose disposal rate and systemic immune inflammation index in non diabetic patients undergoing pci for chronic total occlusion |
| topic | chronic total occlusion (CTO) percutaneous coronary intervention (PCI) estimated glucose disposal rate (eGDR) systemic immune-inflammation index (SII) major adverse cardiovascular events (MACEs) |
| url | https://www.mdpi.com/2308-3425/11/9/261 |
| work_keys_str_mv | AT wenjiechen prognosticvalueofestimatedglucosedisposalrateandsystemicimmuneinflammationindexinnondiabeticpatientsundergoingpciforchronictotalocclusion AT yimingliu prognosticvalueofestimatedglucosedisposalrateandsystemicimmuneinflammationindexinnondiabeticpatientsundergoingpciforchronictotalocclusion AT yuchenshi prognosticvalueofestimatedglucosedisposalrateandsystemicimmuneinflammationindexinnondiabeticpatientsundergoingpciforchronictotalocclusion AT jinghualiu prognosticvalueofestimatedglucosedisposalrateandsystemicimmuneinflammationindexinnondiabeticpatientsundergoingpciforchronictotalocclusion |